{"transactions":[{"id":757696,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-01T22:00:11.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders. The reporting person has elected to defer receipt of the shares of common stock underlying the restricted stock units until the earliest of the following: (i) the fifth anniversary of the date of grant of such restricted stock unit award; (ii) the date that is 30 days following the date on which the director ceases to serve as a member of the board of directors of the Issuer or otherwise provide services to the Issuer; and (iii) a change in control of the Issuer as defined in the Issuer's 2024 Equity Incentive Plan, as amended."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders. The reporting person has elected to defer receipt of the shares of common stock underlying the restricted stock units until the earliest of the following: (i) the fifth anniversary of the date of grant of such restricted stock unit award; (ii) the date that is 30 days following the date on which the director ceases to serve as a member of the board of directors of the Issuer or otherwise provide services to the Issuer; and (iii) a change in control of the Issuer as defined in the Issuer's 2024 Equity Incentive Plan, as amended."}],"balance_after":9311,"derivative":{"underlying":"Common Stock","underlying_shares":9311},"source":{"system":"sec-edgar","filing":"0001604689-26-000009","document":"form4-06012026_060606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000160468926000009/form4-06012026_060606.xml","form_type":"4"}},{"id":757695,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2026-06-01T22:00:11.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":16004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":16004,"derivative":{"exercise_price":21.66,"expiration_date":"2036-05-28","underlying":"Common Stock","underlying_shares":16004},"source":{"system":"sec-edgar","filing":"0001604689-26-000009","document":"form4-06012026_060606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000160468926000009/form4-06012026_060606.xml","form_type":"4"}},{"id":757694,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-01T22:00:11.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":2010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2026, the date on which an annual meeting of stockholders was held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2026, the date on which an annual meeting of stockholders was held."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2010},"source":{"system":"sec-edgar","filing":"0001604689-26-000009","document":"form4-06012026_060606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000160468926000009/form4-06012026_060606.xml","form_type":"4"}},{"id":757693,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-01T22:00:11.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":2010,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":2010,"source":{"system":"sec-edgar","filing":"0001604689-26-000009","document":"form4-06012026_060606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000160468926000009/form4-06012026_060606.xml","form_type":"4"}},{"id":832701,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-20T22:01:17.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":2010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":2010,"derivative":{"underlying":"Common Stock","underlying_shares":2010},"source":{"system":"sec-edgar","filing":"0001604689-26-000006","document":"form4-03202026_100313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000160468926000006/form4-03202026_100313.xml","form_type":"4"}},{"id":832700,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-20T22:01:17.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":4218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in equal annual installments over three years following the date of grant such that the restricted stock units will be fully vested on the third anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in equal annual installments over three years following the date of grant such that the restricted stock units will be fully vested on the third anniversary of the date of grant."}],"balance_after":4218,"derivative":{"underlying":"Common Stock","underlying_shares":4218},"source":{"system":"sec-edgar","filing":"0001604689-26-000006","document":"form4-03202026_100313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000160468926000006/form4-03202026_100313.xml","form_type":"4"}},{"id":832699,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2026-03-20T22:01:17.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":3565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":3565,"derivative":{"exercise_price":22.5,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":3565},"source":{"system":"sec-edgar","filing":"0001604689-26-000006","document":"form4-03202026_100313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000160468926000006/form4-03202026_100313.xml","form_type":"4"}},{"id":832698,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2026-03-20T22:01:17.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":7482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option will vest in equal annual installments over three years following the date of grant such that the stock option will be fully vested on the third anniversary of the date of grant."}],"balance_after":7482,"derivative":{"exercise_price":22.5,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":7482},"source":{"system":"sec-edgar","filing":"0001604689-26-000006","document":"form4-03202026_100313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000160468926000006/form4-03202026_100313.xml","form_type":"4"}},{"id":3297754,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-30T16:14:39.000Z","date":"2020-01-28","kind":"grant","acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options will vest as to 50% of the total grant on January 9, 2022 and as to the remaining 50% on January 9, 2023."}],"balance_after":48000,"derivative":{"exercise_price":7.06,"expiration_date":"2030-01-27","underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001694665-20-000002","document":"wf-form4_158041886185768.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1694665/000169466520000002/wf-form4_158041886185768.xml","form_type":"4"}},{"id":3297753,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-30T16:14:39.000Z","date":"2020-01-28","kind":"grant","acquired":true,"shares":106000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of January 9, 2020, subject to continued employment on such dates."}],"balance_after":106000,"derivative":{"exercise_price":7.06,"expiration_date":"2030-01-27","underlying":"Common Stock","underlying_shares":106000},"source":{"system":"sec-edgar","filing":"0001694665-20-000002","document":"wf-form4_158041886185768.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694665/000169466520000002/wf-form4_158041886185768.xml","form_type":"4"}},{"id":3694614,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-16T08:48:45.000Z","date":"2019-01-14","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest as to 25% of the total grant on the first anniversary of the grant date with the remainder vesting in equal quarterly installments over a three year period thereafter, subject to continued employment on such dates."}],"balance_after":100000,"derivative":{"exercise_price":13.71,"expiration_date":"2029-01-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001694665-19-000002","document":"wf-form4_154764650865511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694665/000169466519000002/wf-form4_154764650865511.xml","form_type":"4"}},{"id":3939083,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option","published_at":"2018-05-10T18:06:36.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":71497,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the grant date and vests in equal quarterly installments over a three year period thereafter."}],"balance_after":71497,"derivative":{"exercise_price":16,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":71497},"source":{"system":"sec-edgar","filing":"0000899243-18-012422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694665/000089924318012422/doc4.xml","form_type":"4"}},{"id":4066099,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-12T20:26:27.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":217708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options granted will vest annually in 48 equal monthly installments beginning on the first monthly anniversary of the grant date. The Company's Board of Directors also approved on February 8, 2018 that, subject to stockholder approval, Jonathan Poole will receive 257,292 additional options with the same grant date, at the same exercise price and pursuant to the same vesting schedule."}],"balance_after":217708,"derivative":{"exercise_price":0.98,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":217708},"source":{"system":"sec-edgar","filing":"0001457612-18-000014","document":"wf-form4_151848517333702.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761218000014/wf-form4_151848517333702.xml","form_type":"4"}},{"id":4252597,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-24T17:30:17.000Z","date":"2017-07-24","kind":"exercise","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2017 by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on 2/2/2016 and vests in 48 equal monthly installments beginning on the first monthly anniversary of the grant date."}],"balance_after":90000,"derivative":{"exercise_price":3.09,"expiration_date":"2026-02-01","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001604689-17-000006","document":"wf-form4_150093180367725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000160468917000006/wf-form4_150093180367725.xml","form_type":"4"}},{"id":4252596,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-07-24T17:30:17.000Z","date":"2017-07-24","kind":"sale","acquired":false,"shares":45000,"price":6,"value":270000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2017 by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were sold in multiple transactions at a price of $6.00. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold."}],"balance_after":39247,"source":{"system":"sec-edgar","filing":"0001604689-17-000006","document":"wf-form4_150093180367725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000160468917000006/wf-form4_150093180367725.xml","form_type":"4"}},{"id":4252595,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-07-24T17:30:17.000Z","date":"2017-07-24","kind":"exercise","acquired":true,"shares":45000,"price":3.09,"value":139050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2017 by the reporting person."}],"balance_after":84247,"source":{"system":"sec-edgar","filing":"0001604689-17-000006","document":"wf-form4_150093180367725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000160468917000006/wf-form4_150093180367725.xml","form_type":"4"}},{"id":4326576,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-05-10T16:44:19.000Z","date":"2017-05-10","kind":"tax_withholding","acquired":false,"shares":3500,"price":6.13,"value":21455.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover taxes on RSUs that vested on May 3, 2017."}],"balance_after":39247,"source":{"system":"sec-edgar","filing":"0001604689-17-000004","document":"wf-form4_149444904447921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000160468917000004/wf-form4_149444904447921.xml","form_type":"4"}},{"id":4326575,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-05-10T16:44:19.000Z","date":"2017-05-08","kind":"sale","acquired":false,"shares":6213,"price":6.51,"value":40446.63,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.50 to $6.54, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":42747,"source":{"system":"sec-edgar","filing":"0001604689-17-000004","document":"wf-form4_149444904447921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000160468917000004/wf-form4_149444904447921.xml","form_type":"4"}},{"id":4326574,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-05-10T16:44:19.000Z","date":"2017-05-03","kind":"grant","acquired":true,"shares":23810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs were granted in accordance with the Plan and will vest in full 18 months from the grant date, subject to Mr. Poole's continued employment with the Company."}],"balance_after":48960,"source":{"system":"sec-edgar","filing":"0001604689-17-000004","document":"wf-form4_149444904447921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000160468917000004/wf-form4_149444904447921.xml","form_type":"4"}},{"id":4326573,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-05-10T16:44:19.000Z","date":"2017-05-03","kind":"grant","acquired":true,"shares":7937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (\"RSUs\") were granted in accordance with Genocea Biosciences, Inc.'s (the \"Company\") 2014 Equity Incentive Plan (the \"Plan\") and vested immediately upon grant."}],"balance_after":25150,"source":{"system":"sec-edgar","filing":"0001604689-17-000004","document":"wf-form4_149444904447921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000160468917000004/wf-form4_149444904447921.xml","form_type":"4"}},{"id":4413972,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-01T16:17:18.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The option will vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date."}],"balance_after":135000,"derivative":{"exercise_price":4.67,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001604689-17-000002","document":"wf-form4_148840302314907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000160468917000002/wf-form4_148840302314907.xml","form_type":"4"}},{"id":4562080,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":42908,"kind":"person","name":"Poole Jonathan","position":1,"cik":"0001604689","reported_name":"Poole Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-11-09T17:32:02.000Z","date":"2016-11-07","kind":"purchase","acquired":true,"shares":7000,"price":3.34,"value":23380.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount adjusted to reflect shares acquired under the registrant's Employee Stock Purchase Plan."}],"balance_after":17213,"source":{"system":"sec-edgar","filing":"0001604689-16-000007","document":"wf-form4_147873070879127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000160468916000007/wf-form4_147873070879127.xml","form_type":"4"}}]}